PATENT CLAIM ANALYSIS

Application Number: 15763248
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "303000"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , and R 5  are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Claim (Index 52):
A method of treating a condition selected from cancer, neurodegenerative disorders or metabolic disorders in a subject in need thereof, comprising administration of an effective amount of the compound according to  claim 34 , alone or in combination with one or more pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 90.0
- Lexical Diversity: 1.41176
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13266976', '14389336', '10524204', '11939735', '12089050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685252105887046
- 35 USC 102 Novelty (BERT): 0.5409078733115289
- Combined Prediction Score: 0.7457634768609871
- Mean Citation Score: 355.59789000000006
- Max Citation Score: 376.5085
- Similarity Product: 235.7944732606412

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test